Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.1500 (-3.15%) ($6.1000 - $6.2500) on Wed. Nov. 23, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.08% (three month average) | RSI | 58 | Latest Price | $6.1500(-3.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.6% a day on average for past five trading days. | Weekly Trend | CGEN advances 1.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IPO(5%) EWG(4%) URA(4%) TBT(3%) EWI(2%) | Factors Impacting CGEN price | CGEN will decline at least -1.04% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-7%) TIP(-7%) TAN(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.04% (StdDev 2.08%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $6.2 | 5 Day Moving Average | $6.32(-2.69%) | 10 Day Moving Average | $6.48(-5.09%) | 20 Day Moving Average | $6.2(-0.81%) | To recent high | -17% | To recent low | 9.8% | Market Cap | $509m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |